Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Developments in 3D Bio-Printing and Its Biomedical Applications. | Pharmaceutics | 2023 | 36678884 | PubTator, text mining | PubMed |
| Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances. | Cancers (Basel) | 2023 | 36672482 | PubTator, text mining | PubMed |
| Identification of the Interaction between Minichromosome Maintenance Proteins and the Core Protein of Hepatitis B Virus. | Curr Issues Mol Biol | 2023 | 36661536 | PubTator, text mining | PubMed |
| The role of different viral biomarkers on the management of chronic hepatitis B. | Clin Mol Hepatol | 2023 | 36655304 | PubTator, text mining | PubMed |
| Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet. | BMC Cancer | 2023 | 36650455 | PubTator, text mining | PubMed |
| Reduction in Intrahepatic cccDNA and Integration of HBV in Chronic Hepatitis B Patients with a Functional Cure. | J Clin Transl Hepatol | 2023 | 36643049 | PubTator, text mining | PubMed |
| Large-scale perfused tissues via synthetic 3D soft microfluidics. | Nat Commun | 2023 | 36635264 | PubTator, text mining | PubMed |
| Psoralea corylifolia L.: a comprehensive review of its botany, traditional uses, phytochemistry, pharmacology, toxicology, quality control and pharmacokinetics. | Chin Med | 2023 | 36627680 | PubTator, text mining | PubMed |
| Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. | Hepatology | 2023 | 36626642 | PubTator, text mining | PubMed |
| Knockout of secretin ameliorates biliary and liver phenotypes during alcohol-induced hepatotoxicity. | Cell Biosci | 2023 | 36624475 | PubTator, text mining | PubMed |
| Long-term cell fate and functional maintenance of human hepatocyte through stepwise culture configuration. | FASEB J | 2023 | 36607308 | PubTator, text mining | PubMed |
| Biological tuners to reshape the bile acid pool for therapeutic purposes in non-alcoholic fatty liver disease. | Clin Sci (Lond) | 2023 | 36601783 | PubTator, text mining | PubMed |
| Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells. | J Clin Invest | 2023 | 36594467 | PubTator, text mining | PubMed |
| Targeting SARS-CoV-2 and host cell receptor interactions. | Antiviral Res | 2023 | 36581047 | PubTator, text mining | PubMed |
| New approach methodologies: A quantitative in vitro to in vivo extrapolation case study with PFASs. | Food Chem Toxicol | 2023 | 36535450 | PubTator, text mining | PubMed |
| Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection. | Antimicrob Agents Chemother | 2023 | 36519892 | PubTator, text mining | PubMed |
| Epidemiology, presentation, and therapeutic approaches for hepatitis D infections. | Expert Rev Anti Infect Ther | 2023 | 36519386 | PubTator, text mining | PubMed |
| Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus. | Virus Res | 2023 | 36511290 | PubTator, text mining | PubMed |
| DrugCentral 2023 extends human clinical data and integrates veterinary drugs. | Nucleic Acids Res | 2023 | 36484092 | PubTator, text mining | PubMed |
| Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals. | Int J Pept Res Ther | 2023 | 36466430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=28